Mastodawn

Daewoong Pharmaceutical announced that its US stem cell partner Immplacate, in which it holds a 20% stake, has entered liquidation, raising questions about investment recovery.
#YonhapInfomax #DaewoongPharmaceutical #Immplacate #StemCellTherapy #Liquidation #InvestmentRecovery #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=91984

Daewoong Pharmaceutical Initiates Liquidation Process for US Stem Cell Partner with 20% Stake

Daewoong Pharmaceutical announced that its US stem cell partner Immplacate, in which it holds a 20% stake, has entered liquidation, raising questions about investment recovery.

Yonhap Infomax